Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and remains the most common life-shortening diseases affecting the exocrine organs. The absence of this channel results in an imbalance of ion concentrations across the cell membrane an...
Saved in:
Main Authors: | Pauline Bardin (Author), Florence Sonneville (Author), Harriet Corvol (Author), Olivier Tabary (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
by: Christie Mitri, et al.
Published: (2020) -
MicroRNA Dysregulation in Cystic Fibrosis
by: Paul J. McKiernan, et al.
Published: (2015) -
Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients
by: Anastasia Tchoukaev, et al.
Published: (2018) -
SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
by: Harriet Corvol, et al.
Published: (2018) -
Emerging Therapeutic Approaches for Cystic Fibrosis
Published: (2020)